128 related articles for article (PubMed ID: 17291487)
21. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
Byrnes EM; Bruno JP
Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
[TBL] [Abstract][Full Text] [Related]
22. The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors.
Popoli P; Pèzzola A; Torvinen M; Reggio R; Pintor A; Scarchilli L; Fuxe K; Ferré S
Neuropsychopharmacology; 2001 Oct; 25(4):505-13. PubMed ID: 11557164
[TBL] [Abstract][Full Text] [Related]
23. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
24. Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D(1) but not D(2) receptor agonists.
Cauli O; Pinna A; Morelli M
Behav Pharmacol; 2005 Dec; 16(8):621-6. PubMed ID: 16286813
[TBL] [Abstract][Full Text] [Related]
25. Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists.
Berridge KC; Aldridge JW
Synapse; 2000 Sep; 37(3):205-15. PubMed ID: 10881042
[TBL] [Abstract][Full Text] [Related]
26. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
[TBL] [Abstract][Full Text] [Related]
27. Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.
Duarte C; Alonso R; Bichet N; Cohen C; Soubrié P; Thiébot MH
Neuropsychopharmacology; 2004 May; 29(5):911-20. PubMed ID: 14694354
[TBL] [Abstract][Full Text] [Related]
28. Differential role of dopamine D1 and D2 receptors in isoniazid-induced vacuous chewing movements.
Naidu PS; Kulkarni SK
Methods Find Exp Clin Pharmacol; 2000 Dec; 22(10):747-51. PubMed ID: 11346896
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of postsynaptic sensitivity to dopaminergic agonists induced by neonatal hippocampal lesions.
Wan RQ; Corbett R
Neuropsychopharmacology; 1997 Apr; 16(4):259-68. PubMed ID: 9094143
[TBL] [Abstract][Full Text] [Related]
30. The Ras homolog Rhes affects dopamine D1 and D2 receptor-mediated behavior in mice.
Quintero GC; Spano D; Lahoste GJ; Harrison LM
Neuroreport; 2008 Oct; 19(16):1563-6. PubMed ID: 18845937
[TBL] [Abstract][Full Text] [Related]
31. Effects of intrastriatal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system.
Sañudo-Peña MC; Force M; Tsou K; Miller AS; Walker JM
Synapse; 1998 Oct; 30(2):221-6. PubMed ID: 9723792
[TBL] [Abstract][Full Text] [Related]
32. Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviors.
Braun AR; Barone P; Chase TN
Adv Exp Med Biol; 1986; 204():151-66. PubMed ID: 2947426
[No Abstract] [Full Text] [Related]
33. Dopamine agonists increase perseverative instrumental responses but do not restore habit formation in a rat model of Parkinsonism.
Faure A; Leblanc-Veyrac P; El Massioui N
Neuroscience; 2010 Jun; 168(2):477-86. PubMed ID: 20362642
[TBL] [Abstract][Full Text] [Related]
34. Blockade of the serotonergic system counteracts the dizocilpine-induced changes in dopaminergic function.
Dall'Olio R; Gandolfi O; Gaggi R
Behav Pharmacol; 2000 Feb; 11(1):29-36. PubMed ID: 10821206
[TBL] [Abstract][Full Text] [Related]
35. Effects of kappa receptor agonists on D1 and D2 dopamine agonist and antagonist-induced behaviors.
Marin C; Engber TM; Chaudhuri P; Peppe A; Chase TN
Psychopharmacology (Berl); 1996 Jan; 123(2):215-21. PubMed ID: 8741947
[TBL] [Abstract][Full Text] [Related]
36. Repeated stimulation of dopamine D1 receptors enhances the effects of dopamine receptor agonists.
White FJ; Hu XT; Brooderson RJ
Eur J Pharmacol; 1990 Dec; 191(3):497-9. PubMed ID: 1982272
[No Abstract] [Full Text] [Related]
37. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
38. Dopamine receptor agonists alter gap prestimulus modulation.
Leitner DS; Girten EM
Psychopharmacology (Berl); 1997 Dec; 134(3):213-20. PubMed ID: 9438671
[TBL] [Abstract][Full Text] [Related]
39. Adenosine A1 receptor blockade selectively potentiates the motor effects induced by dopamine D1 receptor stimulation in rodents.
Popoli P; Giménez-Llort L; Pezzola A; Reggio R; Martínez E; Fuxe K; Ferré S
Neurosci Lett; 1996 Nov; 218(3):209-13. PubMed ID: 8945765
[TBL] [Abstract][Full Text] [Related]
40. Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system.
Sañudo-Peña MC; Patrick SL; Patrick RL; Walker JM
Neurosci Lett; 1996 Mar; 206(1):21-4. PubMed ID: 8848272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
